[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FR2937549B1 - NANOPARTICLES OF BETA-LACTAMINE DERIVATIVES - Google Patents

NANOPARTICLES OF BETA-LACTAMINE DERIVATIVES

Info

Publication number
FR2937549B1
FR2937549B1 FR0857355A FR0857355A FR2937549B1 FR 2937549 B1 FR2937549 B1 FR 2937549B1 FR 0857355 A FR0857355 A FR 0857355A FR 0857355 A FR0857355 A FR 0857355A FR 2937549 B1 FR2937549 B1 FR 2937549B1
Authority
FR
France
Prior art keywords
lactamine
nanoparticles
beta
derivatives
lactamine derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0857355A
Other languages
French (fr)
Other versions
FR2937549A1 (en
Inventor
Patrick Couvreur
Didier Desmaele
Fatima Zouhiri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Universite Paris Sud Paris 11
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR0857355A priority Critical patent/FR2937549B1/en
Priority to CA2742650A priority patent/CA2742650A1/en
Priority to PCT/IB2009/054780 priority patent/WO2010049899A1/en
Priority to EP09759782A priority patent/EP2355800A1/en
Priority to US13/126,756 priority patent/US20110269731A1/en
Priority to JP2011533880A priority patent/JP2012507502A/en
Publication of FR2937549A1 publication Critical patent/FR2937549A1/en
Application granted granted Critical
Publication of FR2937549B1 publication Critical patent/FR2937549B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR0857355A 2008-10-29 2008-10-29 NANOPARTICLES OF BETA-LACTAMINE DERIVATIVES Expired - Fee Related FR2937549B1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR0857355A FR2937549B1 (en) 2008-10-29 2008-10-29 NANOPARTICLES OF BETA-LACTAMINE DERIVATIVES
CA2742650A CA2742650A1 (en) 2008-10-29 2009-10-28 Nanoparticles of beta-lactam derivatives
PCT/IB2009/054780 WO2010049899A1 (en) 2008-10-29 2009-10-28 Nanoparticles of beta-lactam derivatives
EP09759782A EP2355800A1 (en) 2008-10-29 2009-10-28 Nanoparticles of beta-lactam derivatives
US13/126,756 US20110269731A1 (en) 2008-10-29 2009-10-28 Nanoparticles of beta-lactam derivatives
JP2011533880A JP2012507502A (en) 2008-10-29 2009-10-28 Nanoparticles of beta-lactam derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0857355A FR2937549B1 (en) 2008-10-29 2008-10-29 NANOPARTICLES OF BETA-LACTAMINE DERIVATIVES

Publications (2)

Publication Number Publication Date
FR2937549A1 FR2937549A1 (en) 2010-04-30
FR2937549B1 true FR2937549B1 (en) 2011-04-01

Family

ID=40599981

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0857355A Expired - Fee Related FR2937549B1 (en) 2008-10-29 2008-10-29 NANOPARTICLES OF BETA-LACTAMINE DERIVATIVES

Country Status (6)

Country Link
US (1) US20110269731A1 (en)
EP (1) EP2355800A1 (en)
JP (1) JP2012507502A (en)
CA (1) CA2742650A1 (en)
FR (1) FR2937549B1 (en)
WO (1) WO2010049899A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2931152B1 (en) * 2008-05-16 2010-07-30 Centre Nat Rech Scient NEW NUCLEIC ACID TRANSFER SYSTEM
FR2937537A1 (en) 2008-10-29 2010-04-30 Centre Nat Rech Scient NANOPARTICLES OF STATIN
EP2344277B1 (en) * 2008-10-31 2018-06-27 Hitachi Koki CO., LTD. Centrifuge
FR2988092B1 (en) 2012-03-16 2014-04-25 Centre Nat Rech Scient COMPLEXES OF VITAMIN C, NANOPARTICLES OF SAID COMPLEXES, PROCESSES FOR THEIR PREPARATION, COMPOSITIONS, COSMETIC USES, AND COSMETIC TREATMENT PROCESS
EP2742955A1 (en) 2012-12-12 2014-06-18 Centre National De La Recherche Scientifique Nanoparticles based on bioconjugate of GAG
CN108290845B (en) * 2015-10-07 2021-08-03 大日本住友制药株式会社 Pyrimidine compounds
EP3463479A2 (en) 2016-06-02 2019-04-10 Advanced Scientific Developements Pharmaceutical formulation comprising cineol and amoxicillin
MX2021000951A (en) 2018-07-23 2021-06-23 Sumitomo Pharma Co Ltd Composition containing influenza vaccine.
FR3110427B1 (en) 2020-05-20 2023-07-14 Laboratoires Eriger Coupling terpene conjugate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000053207A1 (en) * 1999-03-09 2000-09-14 Ganomycin Gesellschaft Für Biomedizinische Forschung Mbh ; Biologically active compounds of $i(ganoderma pfeifferi) dms 13239
KR100564021B1 (en) * 2002-12-11 2006-03-24 주식회사종근당 Oral formulations for poorly absorptive hydrophilic drugs
FR2874016B1 (en) * 2004-06-30 2006-11-24 Centre Nat Rech Scient Cnrse NANOPARTICLES OF DERIVATIVES OF GEMCITABINE
FR2937537A1 (en) * 2008-10-29 2010-04-30 Centre Nat Rech Scient NANOPARTICLES OF STATIN

Also Published As

Publication number Publication date
US20110269731A1 (en) 2011-11-03
WO2010049899A1 (en) 2010-05-06
EP2355800A1 (en) 2011-08-17
FR2937549A1 (en) 2010-04-30
JP2012507502A (en) 2012-03-29
CA2742650A1 (en) 2010-05-06

Similar Documents

Publication Publication Date Title
BRPI0906436A2 (en) Phthalazinone derivatives
DK2308877T3 (en) Imidazopyridine-2-one derivatives
BRPI0913832A2 (en) pyrrolopyridinylpyrimidin-2-ylamine derivatives
BRPI0915064A2 (en) qunoxalinadione derivatives
BRPI1013246A2 (en) benzofuralin derivatives
BR112012002828A2 (en) 5-fluorpyrimidinone derivatives
BR112012015868A2 (en) imidazolidinedione derivatives
ECSP12011999A (en) SUBSTITUTED BENZAMIDA DERIVATIVES
BRPI0919447A2 (en) 1-amino-2-cyclobutylethylboronic acid derivatives
BRPI0914544A2 (en) substituted pyrimidone derivatives
FR2937549B1 (en) NANOPARTICLES OF BETA-LACTAMINE DERIVATIVES
BRPI1013844A2 (en) pyridine-isoxazole derivatives
DK2275414T3 (en) CYCLOPENTYLACRYLAMIDE DERIVATIVES
DK2397480T3 (en) DIAZEPINDION DERIVATIVES
BRPI0914301A2 (en) substituted pyrimidin-4-one derivatives
ATE545635T1 (en) SUBSTITUTED N-OXIDEPYRAZINE DERIVATIVES
DK2318378T3 (en) Quinazoline derivatives
BRPI1014454A2 (en) isoxazol-pyrazole derivatives
BRPI0913234A2 (en) thiazolylpiperidine derivatives
BRPI0906357A2 (en) Substituted oxazepinopyrimidone arylamide derivatives
BR112012016923A2 (en) Pyrazole Derivatives
DK2387580T3 (en) Deoxyactagardine derivatives
BRPI0907963A2 (en) Indazole Derivatives
BRPI0922652A2 (en) Quinazolinamide derivatives
ATE534634T1 (en) 2-PHENYL-4-CYCLOPROPYL-PYRIMIDINE DERIVATIVES

Legal Events

Date Code Title Description
TQ Partial transmission of property

Owner name: UNIVERSITE PARIS SUD, FR

Effective date: 20110930

Owner name: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (, FR

Effective date: 20110930

PLFP Fee payment

Year of fee payment: 8

ST Notification of lapse

Effective date: 20170630